Sanofi (SNY) Total Non-Current Liabilities (2009 - 2026)

Sanofi has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $32.0 billion for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities rose 10.47% year-over-year to $32.0 billion; the TTM figure through Jun 2026 stood at $32.0 billion (up 10.47% YoY), while the FY2025 annual figure was $31.1 billion, up 11.6% from the prior year.
• Total Non-Current Liabilities came in at $32.0 billion for Q2 2026 at Sanofi, up from $31.1 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $32.0 billion in Q2 2026 to a low of $27.5 billion in Q4 2024.
• Average Total Non-Current Liabilities over 5 years is $29.7 billion, with a median of $30.0 billion recorded in 2023.
• Year-over-year, Total Non-Current Liabilities declined 17.73% in 2022 and increased 13.04% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $28.2 billion in 2022, then climbed by 6.64% to $30.0 billion in 2023, then fell by 8.25% to $27.5 billion in 2024, then increased by 13.04% to $31.1 billion in 2025, then climbed by 2.89% to $32.0 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $32.0 billion in Q2 2026, $31.1 billion in Q4 2025, and $29.0 billion in Q2 2025.